4.4 Article

Growing pains in children: Epidemiological analysis in a Mediterranean population

期刊

JOINT BONE SPINE
卷 76, 期 5, 页码 486-490

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.jbspin.2009.09.001

关键词

Growing pains; Children; Epidemiology

向作者/读者索取更多资源

Objectives: Recurrent lower limb pains (growing pains) constitute the most frequent cause of musculoskeletal pain in children. Despite the fact that the international literature has presented numerous cases over the years, which have led to various hypotheses and theories, the disorder's exact nature and aetiology remain unclear. Methods: Our study aims to examine both the epidemiological profile of the children affected by the disorder and the measures taken by parents or medical specialists for their management. In addition, we tried to link the existing theories with the findings of our study, to ascertain whether these were verified by the epidemiological findings. This retrospective study investigated the appearance of lower limbs in the 12-month period before the visit of the children to our department. The study included a total of 532 children, aged 4-12, while the data were collected through semi-structured interviews including a mix of open and closed questions. Results: One hundred and thirty of these children presented growing pains, meeting Petersen's criteria. The frequency of the disorder was 24.5%. Most times, they appeared after intensive physical exercise, while their development was not linked to the children's BMI. The main therapeutic approach used by parents was massaging the painful lower limbs and, to a lesser extent, the administration of anti-inflammatory agents. Conclusions: The data analysis proves that this is a benign disorder with an unknown pathophysiological mechanism. In addition, their presence is not strongly related to anatomic or orthopaedic disorders, a fact opposing anatomical theory. On the contrary, their appearance after intensive physical exercise at a percentage of up to 78.5% leads us to hypothesise that it is a lower local extremity overuse syndrome, which seems in accordance with many experimental data in international literature. (C) 2009 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
Review Rheumatology

Evolution of musculoskeletal symptoms in Long COVID syndrome: a lexical analysis to approach requirements for an interdisciplinary management

Maria Chiara Maccarone, Daniele Coraci, Gianluca Regazzo, Nicola Sarandria, Anna Scanu, Stefano Masiero

Summary: Long COVID syndrome refers to the new, returning, or persistent symptoms after the initial SARS-CoV-2 infection. Musculoskeletal symptoms have a significant impact on the quality of life in many patients. A literature review was conducted to explore the evolution of musculoskeletal symptoms in Long COVID syndrome. The findings highlight the need for interdisciplinary management and timely rehabilitative interventions.

JOINT BONE SPINE (2024)

Review Rheumatology

Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs)

Alexis Mathian, Renaud Felten, Marta E. Alarcon-Riquelme, Antony Psarras, Philippe Mertz, Francois Chasset, Edward M. Vital, Laurent Arnaud

Summary: Improved understanding of the molecular basis of innate immunity has led to the recognition of type I interferons (IFNs) as key mediators in the development of immunemediated inflammatory diseases (IMIDs). Pharmacological targeting of IFNs and their downstream signaling pathways, such as JAK1 and Tyk2, holds promise for the treatment of IMIDs.

JOINT BONE SPINE (2024)

Review Rheumatology

Platelets are a major player and represent a therapeutic opportunity in systemic lupus erythematosus

Marie Robert, Marc Scherlinger

Summary: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune dysregulation and organ injury, involving the active role of platelets in the pathogenesis and disease progression. Platelets in SLE patients show intrinsic differences and can perpetuate inflammation by interacting with immune cells, thereby participating in organ damage and heightened cardiovascular mortality.

JOINT BONE SPINE (2024)

Review Rheumatology

Mind-body practices in chronic inflammatory arthritis

Jean Sibilia, Fabrice Berna, Jean-Gerard Bloch, Marc Scherlinger

Summary: Mind-body practices, such as mindfulness meditation, yoga, and Tai Chi, show promise in improving patient-reported outcomes in chronic rheumatic diseases, but their impact on inflammation and structural progression remains unclear.

JOINT BONE SPINE (2024)

Review Rheumatology

Weight loss affects disease activity and treatment response in inflammatory rheumatic diseases

Anne Tournadre, Marine Beauger

Summary: Obesity alters the characteristics of adipose tissue, leading to chronic low-grade inflammation, increased risk of chronic inflammatory diseases, and impact on treatment efficacy. Dietary and weight adjustments have a positive effect on improving inflammatory rheumatic diseases.

JOINT BONE SPINE (2024)

Article Rheumatology

BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre with score

Romain Fore, Eric Liozon, Stephanie Dumonteil, Thomas Sene, Emmanuel Heron, Valentin Lacombe, Mathilde Leclercq, Julie Magnant, Clement Beuvon, Alexis Regent, Donatienne de Mornac, Maxime Samson, Perrine Smets, Jean-Francois Alexandra, Brigitte Granel, Pierre-Yves Robert, Muhammad Faiz Curumthaullee, Simon Parreau, Sylvain Palat, Holy Bezanahary, Kim Heang Ly, Anne-Laure Fauchais, Guillaume Gondran

Summary: This study aimed to evaluate whether the use of intravenous pulse of methylprednisolone reduces the risk of bilateral visual ischemia in patients with giant cell arteritis. The results showed no significant difference in the incidence of bilateral visual ischemia between the group receiving intravenous pulse of methylprednisolone and the group receiving direct prednisone.

JOINT BONE SPINE (2024)

Review Rheumatology

Osteoarthritis in patients with obesity: The bariatric surgery impacts on its evolution

Florent Eymard, Judith Aron-Wisnewsky

Summary: Obesity is a major modifiable risk factor for osteoarthritis (OA) and is associated with poorer outcomes in terms of pain, functional limitations, and response to treatments. Bariatric surgery (BS) can significantly reduce symptoms and improve function in patients with symptomatic knee OA, but its impact on long-term complications of arthroplasties appears to be disappointing. Overall, BS shows promise in reducing OA symptoms and potentially slowing disease progression.

JOINT BONE SPINE (2024)

Review Rheumatology

Senescence-regulatory factors as novel circulating biomarkers and therapeutic targets in regenerative medicine for osteoarthritis

Georges Marouna, Christina Fissouna, Marina Villaverde, Jean-Marc Brondelloa, Yves-Marie Pers

Summary: Recent discoveries have shown that the presence of senescent cells in osteoarticular tissues plays a crucial role in the development of osteoarthritis (OA). However, the senescence-regulatory factors associated with OA still need to be identified. Additionally, there is a lack of diagnostic and prognostic biomarkers currently used in clinics to evaluate OA patients. In the future, detecting senescence-regulatory biomarkers in patient fluids, along with imaging and clinical examination, could become a promising method for diagnosing, monitoring, assessing progression, and predicting prognosis in OA patients.

JOINT BONE SPINE (2024)

Article Rheumatology

Disease characteristics, pathogenesis, and treatment controversies of axial psoriatic arthritis

Patrick Yousif, Vicky Nahra, Muhammad A. Khan, Marina Magrey

Summary: Axial psoriatic arthritis (axPsA) has unique clinical and radiographic features compared to axial spondyloarthritis (axSpA). IL-23 inhibitors may be effective in treating axPsA, but further clinical trials are needed. Developing classification criteria and assessment tools for axPsA is also necessary.

JOINT BONE SPINE (2024)

Review Rheumatology

How to treat chronic pain in rheumatic and musculoskeletal diseases (RMDs) - A pharmacological review

Baptiste Gerard, Florian Bailly, Anne-Priscille Trouvin

Summary: This review aims to critically evaluate the effectiveness and safety of pharmacological treatments for chronic pain in rheumatic diseases, providing guidance for clinicians in selecting appropriate treatment options. The recommended pharmacological treatments vary depending on the specific rheumatic disease.

JOINT BONE SPINE (2024)